Table of Contents Table of Contents
Previous Page  928 / 1082 Next Page
Information
Show Menu
Previous Page 928 / 1082 Next Page
Page Background

S912

ESTRO 36 2017

_______________________________________________________________________________________________

dose rate image-guided uterovaginal brachytherapy of 15

Gy.

The primary tumor was delineated on the PET images using

a fixed threshold (40% of SUV

max

) within a manually drawn

volume of interest (VOI), called VOI-T. A 73 mL sphere was

drawn in the healthy liver considered as homogeneous

(VOI-L). For each VOI, 5 conventional indices (SUV

mean

,

SUV

max

, SUV

peak

in a 1 mL sphere, metabolic volume, tumor

lesion glycolysis) and 6 3D textural indices were calculated

after resampling the VOI SUV between 0 and 40 using 128

gray levels: Homogeneity and Entropy from the Gray-Level

Co-occurrence Matrix, Short-Run Emphasis (SRE), Long-

Run Emphasis (LRE), Low Gray-level Zone Emphasis (LGZE)

and High Gray-level Zone Emphasis (HGZE).

Wilcoxon’s tests were performed between G1 and G2 in

VOI-L to determine to what extent technological

differences and image properties influence radiomic

feature values. A stepwise model selection using the

Akaike Information Criterion was applied to determine the

best 4-feature signature for local recurrence prediction in

both groups, used successively for training and validation.

Delong’s tests between AUC were performed to evaluate

if the signature was more powerful than SUV

max

only.

Results

SUV

max

, SUV

peak

, Homogeneity and SRE computed in VOI-L

were significantly different between the two devices

(p<0.05). These p-values suggested that data coming from

the two PET devices can therefore not be gathered.

In G1, the best 4-feature signature was a combination of

Entropy, SUV

mean

, SUV

max

and SRE (AUC=0.77) and in G2, a

combination of SUV

peak

, Homogeneity, LGZE, HGZE

(AUC=0.86). G2 signature was validated in G1 with

AUC=0.76 and was significantly more powerful than SUV

max

according to Delong’s test (p=0.02). G1 signature was not

validated in G2, yielding to an AUC less than that obtained

with SUV

max

only.

Conclusion

Some conventional and textural features are strongly

dependent on the PET device and acquisition parameters

such as voxel size. A robustness analysis should be

performed before each multi-centric radiomic study, to

evaluate the possibility of gathering data from different

devices. Multivariate analysis showed that radiomic

features can predict LACC local recurrence with a better

accuracy than SUV

max

for recent PET devices. The creation

of an external validation cohort is in progress to confirm

the results.

EP-1693 Functional MRI to individualize PTV margins

to seminal vesicles with suspected cancer involvement

S. Damkjaer

1

, J. Thomsen

1

, S. Petersen

1

, J. Bangsgaard

1

,

M. Aznar

2

, I. Vogelius

1

, P. Petersen

1

1

Rigshospitalet, Department of Oncology- Section for

Radiotherapy - 3994, København, Denmark

2

University of Oxford, Clinical Trial Service Unit- Richard

Doll Building, Oxford, United Kingdom

Purpose or Objective

For external beam radiotherapy of prostate cancer

patients, the information from pre-treatment MRIs can

give patient specific and visual evaluation of suspected

pathologically involved volumes in the seminal vesicles

(SV) as an important addition to probability based

nomograms [1]. We investigate the impact of